Rx (Prescription Medicine)
USD $ 1,300.00
海姆立布 30毫克注射液用于预防或减少A型血友病患者的出血发作。本品需遵医嘱通过皮下注射给药。
海姆立布 30毫克注射液是一种突破性药物，专为治疗A型血友病而设计。其活性成分艾美赛珠单抗（emicizumab）是一种双特异性单克隆抗体，可模拟A型血友病患者体内缺失的凝血因子功能。通过连接活化的凝血因子IX和凝血因子X，艾美赛珠单抗促进凝血酶原转化为凝血酶，从而促进血凝块形成并减少出血发作的频率。海姆立布通过皮下注射给药，用于A型血友病患者（无论是否伴有因子VIII抑制物）的常规预防，以预防或减少出血频率。严格按照您的医疗保健提供者的处方使用海姆立布至关重要。将注射液在室温下储存并避光。请勿冷冻。如对本品的使用或潜在副作用有任何疑问，请务必咨询您的医生。
| Medicine Form | |
|---|---|
| Rx Status | |
| Medicine Type | |
| Molecule | |
| Brand Name | |
| Pack Quantity | |
| Strength |
未库存此 exact 强度的其他品牌，因此这些是其他强度的 Emicizumab. 未经开方医生建议，请勿更改剂量。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
